Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagy

Cancer Research

Volumn 67, Issue 13, 2007, Pages 6293-6303

  Ohtani, Shoichiro ^a   Iwamaru, Arifumi ^a   Deng, Wuguo ^a   Ueda, Kentaro ^a   Wu, Guanglin ^a   Jayachandran, Gitanjali ^a   Kondo, Seiji ^b   Atkinson, Edward N ^b   Minna, John D ^c   Roth, Jack A ^a   Ji, Lin ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ASCORBIC ACID; HYDROGEN PEROXIDE; NANOPARTICLE; PLASMID VECTOR; TUMOR SUPPRESSOR 101F6; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; BRONCHUS MUCOSA; COMPUTER AIDED DESIGN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG POTENTIATION; DRUG UPTAKE; EPITHELIUM CELL; EXPERIMENTAL NEOPLASM; GENE TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG FIBROBLAST; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SYSTEMIC THERAPY; VIRAL GENE THERAPY;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; AUTOPHAGY; CARCINOMA, NON-SMALL-CELL LUNG; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOSOME MAPPING; CYTOCHROME B GROUP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; NANOPARTICLES; TUMOR SUPPRESSOR PROTEINS;

EID: 34447128187     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-3884     Document Type: Article

References (40)

1. Ji L, Nishizaki M, Gao B, et al. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res 2002;62:2715-20.
2. Ji L, Minna JD, Roth JA. 3p21.3 tumor suppressor cluster: prospects for translational applications. Future Oncol 2005;1:79-92.
3. Lerman MI, Minna JD; The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. Cancer Res 2000;60:6116-33.
4. Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 2002;21:6915-35.
5. Bashtovyy D, Berczi A, Asard H, et al. Structure prediction for the di-heme cytochrome b561 protein family. Protoplasma 2003;221:31-40.
6. Tsubaki M, Takeuchi F, Nakanishi N, et al. Cytochrome b561 protein family: expanding roles and versatile transmembrane electron transfer abilities as predicted by a new classification system and protein sequence motif analyses. Biochim Biophys Acta 2005;1753:174-90.
7. Verelst W, Asard H. A phylogenetic study of cytochrome b561 proteins. Genome Biol 2003;4:R38.
8. Ponting CP. Domain homologues of dopamine β-hydroxylase and ferric reductase: roles for iron metabolism in neurodegenerative disorders? Hum Mol Genet 2001;10:1853-8.
9. Padayatty SJ, Riordan HD, Hewitt SM, et al. Intravenously administered vitamin C as cancer therapy: three cases. Can Med Assoc J 2006;174:937-42.
10. Chen Q, Espey MG, Krishna MC, et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A 2005;102:13604-9.
11. Block KI, Mead MN, Block KI, et al. Vitamin C in alternative cancer treatment: historical background. Integr Cancer Ther 2003;2:147-54.
12. Tamayo C, Richardson MA, Tamayo C, et al. Vitamin C as a cancer treatment: state of the science and recommendations for research. Altern Ther Health Med 2003;9:94-101.
13. Calderon PB, Cadrobbi J, Marques C, et al. Potential therapeutic application of the association of vitamins C and K3 in cancer treatment. Curr Med Chem 2002;9:2271-85.
14. Gottlieb N, Gottlieb N. Cancer treatment and vitamin C: the debate lingers. J Natl Cancer Inst 1999;91:2073-5.
15. Podmore ID, Griffiths HR, Herbert KE, et al. Vitamin C exhibits pro-oxidant properties. Nature 1998;392:559.
16. You WC, Chang YS, Heinrich J, et al. An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity. Eur J Cancer Prev 2001;10:257-63.
17. Padayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med 2004;140:533-7.
18. Casciari JJ, Riordan NH, Schmidt TL, et al. Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours. Br J Cancer 2001;84:1544-50.
19. Ito I, Ji L, Tanaka F, et al. Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo. Cancer Gene Ther 2004;11:733-9.
20. Uno F, Sasaki J, Nishizaki M, et al. Myristoylation of the fus1 protein is required for tumor suppression in human lung cancer cells. Cancer Res 2004;64:2969-76.
21. Nishizaki M, Meyn RE, Levy LB, et al. Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo. Clin Cancer Res 2001;7:2887-97.
22. Yang P, Felix E, Madden T, et al. Quantitative high-performance liquid chromatography/electrospray ionization tandem mass spectrometric analysis of 2- and 3-series prostaglandins in cultured tumor cells. Anal Biochem 2002;308:168-77.
23. Kempen EC, Yang P, Felix E, et al. Simultaneous quantification of arachidonic acid metabolites in cultured tumor cells using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Anal Biochem 2001;297:183-90.
24. Kanzawa T, Kondo Y, Ito H, et al. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res 2003;63:2103-8.
25. Kanzawa T, Germano IM, Komata T, et al. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 2004;11:448-57.
26. Paglin S, Hollister T, Delohery T, et al. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 2001;61:439-44.
27. Kondo Y, Kanzawa T, Sawaya R, et al. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005;5:726-34.
28. Mizushima N, Yamamoto A, Hatano M, et al. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol 2001;152:657-68.
29. Munafo DB, Colombo MI. A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation. J Cell Sci 2001;114:3619-29.
30. Seglen PO, Gordon PB, Seglen PO, et al. 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci U S A 1982;79:1889-92.
31. Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004;23:2891-906.
32. Daido S, Yamamoto A, Fujiwara K, et al. Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy. Cancer Res 2005;65:4368-75.
33. Takeuchi H, Kondo Y, Fujiwara K, et al. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res 2005;65:3336-46.
34. Shao Y, Gao Z, Marks PA, et al. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci U S A 2004;52:18030-65.
35. Broker LE, Kruyt FA, Giaccone G. Cell death independent of caspases: a review. Clin Cancer Res 2005;11:3155-62.
36. Kroemer G, Martin SJ. Caspase-independent cell death. Nat Med 2005;11:725-30.
37. Verrax J, Delvaux M, Beghein N, et al. Enhancement of quinone redox cycling by ascorbate induces a caspase-3 independent cell death in human leukaemia cells. An in vitro comparative study. Free Radic Res 2005;39:649-57.
38. Verrax J, Cadrobbi J, Marques C, et al. Ascorbate potentiates the cytotoxicity of menadione leading to an oxidative stress that kills cancer cells by a non-apoptotic caspase-3 independent form of cell death. Apoptosis 2004;9:223-33.
39. Oberley LW. Anticancer therapy by overexpression of superoxide dismutase. Antioxid Redox Signal 2001;3:461-72.
40. Levine M, Wang Y, Padayatty SJ, et al. A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci U S A 2001;98:9842-6.